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Background: Lateral Epicondylalgia (LE) is a common injury for which no reliable and valid measure exists to
determine severity in the Dutch language. The Patient-Rated Tennis Elbow Evaluation (PRTEE) is the first questionnaire
specifically designed for LE but in English. The aim of this study was to translate into Dutch and cross-culturally adapt
the PRTEE and determine reliability and validity of the PRTEE-D (Dutch version).
Methods: The PRTEE was cross-culturally adapted according to international guidelines. Participants (n = 122) were
asked to fill out the PRTEE-D twice with a one week interval to assess test-retest reliability. Internal consistency of the
PRTEE-D was determined by calculating Crohnbach’s alphas for the questionnaire and subscales. Intraclass Correlation
Coefficients (ICC) were calculated for the overall PRTEE-D score, pain and function subscale and individual questions to
determine test-retest reliability. Additionally, the Disabilities for the Arm, Shoulder and Hand questionnaire (DASH) and
Visual Analogue Scale (VAS) pain scores were obtained from 30 patients to assess construct validity; Spearman’s
correlation coefficients were calculated between the PRTEE-D (subscales) and DASH and VAS-pain scores.
Results: The PRTEE was successfully cross-culturally adapted into Dutch (PRTEE-D). Crohnbach’s alpha for the first
assessment of the PRTEE-D was 0.98; Crohnbach’s alpha was 0.93 for the pain subscale and 0.97 for the function
subscale. ICC for the PRTEE-D was 0.98; subscales also showed excellent ICC values (pain scale 0.97 and function scale
0.97). A significant moderate correlation exists between PRTEE-D and DASH (0.65) and PRTEE-D and VAS pain (0.68).
Conclusion: The PRTEE was successfully cross-culturally adapted and this study showed that the PRTEE-D is reliable
and valid to obtain an indication of severity of LE. An easy-to-use instrument for practitioners is now available and this
facilitates comparing Dutch and international research data.
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Lateral Epicondylalgia (LE), also known as tennis elbow, is
a common injury with a high prevalence especially in a
40–50 year old population [1,2]. The prevalence in the
general population (25–64 years) is 1.3% for males and
1.1% for females [3].
LE is in most cases a tendinopathy of the Extensor Carpi
Radialis Brevis tendon caused by overuse of the extensor
tendons of the forearm [4]. It is characterized by pain and
tenderness near the lateral epicondyle of the humerus, a* Correspondence: m.van.ark@umcg.nl
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reproduction in any medium, provided the orweak and painful grasp and pain with extension of the
wrist and the third metacarpal [5]. Despite the prevalence
of LE, only little consensus exists on its treatment [6,7].
Examples of treatments used for LE in practice are (eccen-
tric) exercise programs, acupuncture, injections, taping,
ESWT and deep friction massage. Further randomized
and controlled studies with reliable outcome measures in-
cluding questionnaires are required to determine the opti-
mal treatment strategy.
The first questionnaire specifically designed for LE
was developed in Canada in 1999. This questionnaire was
called the Patient-Rated Forearm Evaluation Questionnaire
(PRFEQ) [8]. The PRFEQ was developed to provide a brief,
uncomplicated, standardized quantitative description of painl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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severity [8]. The PRFEQ is found to be reliable and sensitive
[8,9]. In 2005, some minor changes were made in the word-
ing of the PRFEQ along with a change of the name in
PRTEE (Patient-Rated Tennis Elbow Evaluation) to improve
the questionnaire [10]. The developers state that the pub-
lished reliability and validity data still apply, because only
minor changes were made to the PRFEQ.
The English-language PRTEE has already been trans-
lated and cross-culturally adapted in Italian, Swedish,
Turkish and Canadian-French [11-14]. Previously the
PRFEQ was translated and cross-culturally adapted into
Hong Kong Chinese [15]. In the Dutch language, less
specific questionnaires for the upper extremity, like the
Disabilities for the Arm, Shoulder and Hand (DASH)
questionnaire, exist. However, a reliable and valid ques-
tionnaire specific for measuring patient perceived sever-
ity of LE is not yet available in Dutch. The cross-cultural
adaptation of the PRTEE would provide such a question-
naire and this would be another step for a universally ac-
cepted outcome measure for LE.
Therefore, the aim of this study is to translate into
Dutch and cross-culturally adapt the PRTEE according
to international guidelines [16]. Furthermore, the reli-




The PRTEE was cross-culturally adapted to the Dutch
language. Subsequently internal consistency, test-retest
reliability and construct validity were assessed. The
Medical Ethical committee of the University Medical
Center Groningen reviewed the study protocol and con-
cluded that the study was not subject to the Medical Re-
search Involving Human Subjects Act. No formal
ethical approval was therefore needed. All participants
received the PRTEE-D questionnaire with an accom-
panying letter, informing about the study and its goals
and explaining that return of the questionnaire will be
taken as consent to participate.
Cross-cultural adaptation
Permission for the cross-cultural adaptation of the
PRTEE to Dutch was obtained from the developer of the
PRTEE (personal communication, Dr. J.C. MacDermid).
The cross-cultural adaptation was performed according
to the five stage guideline for this process in self-report
measures [16].
Stage 1: forward translation
The English PRTEE was translated into Dutch by two
translators. One translator had a medical background
and was aware of the purpose of the translation. Theother translator did not have a medical background and
was not aware of the purpose of the translation.
Stage 2: synthesis of the translations
A synthesis of both translations was developed by reach-
ing consensus between the two translators and an obser-
ver. This synthesis process was documented in a written
report.
Stage 3: back translation (to English)
Two bilingual native English speakers translated the syn-
thesized version of stage 2 back to English. They were not
familiar with the research protocol, the concepts explored
or the PRTEE.
Stage 4: expert committee
An expert committee consisting of a sports medicine
physician, human movement scientist, epidemiologist
and the translators reached consensus on a translation
of the PRTEE. All previous translations of the PRTEE
were taken into consideration to reach this consensus.
The expert committee meeting resulted in a pre-final
version of the PRTEE-D (Patient-Rated Tennis Elbow
Evaluation – Dutch).
Stage 5: pretesting
The final stage of the cross-cultural adaptation of the
PRTEE was pretesting of the questionnaire. Ten persons
filled out the PRTEE-D. After completing the question-
naire each subject was asked to point out any difficulties
in understanding or ambiguities in the questionnaire.
Reliability
‘Reliability’ is a generic term used to indicate both the
homogeneity (internal consistency) of a scale and the repro-
ducibility (test–retest reliability) of scores [17]. Both were
determined for the PRTEE-D. The PRTEE-D was filled out
by 90 healthy participants recruited at universities and
tennis clubs and 32 LE patients diagnosed by a physical
therapist or sports medicine physician. Physiotherapists,
general practitioners and sports physicians in and in the
area of the University Medical Center Groningen were con-
tacted. The clinicians asked patients with diagnosed LE to
participate in the study. Patients were asked to complete
the questionnaire twice with an interval of 1 week to assess
test-retest reliability [17].
Validity
To assess construct validity, the patients also filled out
the DASH questionnaire and indicated degree of pain in
their arm on a Visual Analogue Scale (VAS) the first
time they filled out the PRTEE-D. Criterion validity of
the PRTEE-D was not assessed, because a ‘gold standard’
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The PRTEE provides a score of pain and functional abil-
ity of LE patients over the last week. The questionnaire
consists of two subscales: a pain scale and a function
scale; five questions regarding pain in the elbow and ten
questions regarding the function of the elbow. Answers
have to be given on an eleven point scale with 0 repre-
senting no pain or difficulty in performing a task and 10
representing the worst pain imaginable or unable to do
the task. The maximum score is 50 for the pain subscale
and 100 for the function subscale. The function subscale
was divided by 2. The total score was calculated by add-
ing the scores of the pain and function subscales.
DASH
The Dutch language version of the DASH questionnaire
was found to be reliable and valid for assessing disability
and symptoms in patients with upper limb disorders
[18]. It was designed for any condition in the upper limb
[19]. The DASH questionnaire consists of 30 items, 21
are physical function items, 6 symptom items and 3 so-
cial or role function items. Items refer to situations in
the last week. Answers had to be given on a 5-point
Likert scale, ranging from no difficulty to unable, from
none to extreme, or from no impact to high impact. The
raw score was transformed to a score ranging from 0 to
100. A score of 0 indicates minimal disability and 100
indicates maximal disability.
Visual Analogue Scale (VAS) pain
Patients were asked to indicate the degree of pain in
their arm by drawing a line on a scale (0-100 mm) from
no pain to unbearable pain.
Data analyses
Descriptive statistics (mean, SD) were used to describe
subject’s characteristics. Test-retest reliability was deter-
mined with the Intraclass Correlation Coefficient (ICC
(2,1)). This was done for the overall PRTEE-D score,
pain and function subscore and scores on individual
questions (Two-way mixed effect model absolute agree-
ment). An ICC value < 0.4 was considered to be ‘poor’, a
value of 0.4 – 0.75 was considered to be ‘fair to good’
and an ICC > 0.75 was considered to be excellent [20].
Additionally, to determine absolute agreement, a Bland
and Altman plot was made; the mean difference (d) be-
tween the first and second assessment with correspond-
ing 95% CI and the 95% Limits of Agreement (LOA)
were displayed [21]. As proposed by Bland and Altman,
an absolute agreement exists when zero lies within the95% CI of the mean difference between test and retest
measurement [21]. Internal consistency of the PRTEE-D
was assessed by calculating Cronbach’s alphas for the
total score and subscores. Internal consistency was con-
sidered excellent when Cronbach’s alpha exceeds 0.80,
adequate when Cronbach’s alpha is between 0.70 and
0.79, and inadequate when it is lower than 0.70 [22].
Separate reliability analyses for the LE patients only were
also performed as well as a factor analysis with Principal
Component Analysis.
Construct validity was determined by calculating Spear-
man’s correlation coefficient between the PRTEE-D (sub-
scores) and DASH and VAS-pain scores. Spearman’s rho
correlations were interpreted according to Domholdt [23]:
little, if any 0.00–0.25, low 0.26–0.49, moderate 0.50–0.69,
high 0.70–0.89 and very high 0.90–1.00. An alpha < 0.05
was considered to be significant. Furthermore, a Bland
Altman plot was made to determine whether systematic
bias occurred between PRTEE-D and DASH question-




The PRTEE was successfully cross-culturally adapted into
Dutch. Back translation corresponded well with the ori-
ginal questionnaire, only minor differences were encoun-
tered. All members of the expert committee agreed on the
pre-final version of the PRTEE-D. Pre-testing revealed
that there were no difficulties in understanding or ambi-
guities in the PRTEE-D. Some patients indicated that they
were not able to provide a good answer to some questions
because they always performed that activity with their
non-injured arm. The PRTEE-D is available as a supple-
ment to this article (Additional file 1).
Subjects
Table 1 shows the subject’s characteristics. The PRTEE-
D was filled out twice by 122 participants (47 males, 75
females). Additionally, 30 LE patients (14 males, 16 fe-
males) completed the DASH questionnaire and a VAS-
pain score.
Internal consistency
The Crohnbach’s alpha for the first assessment of the
PRTEE-D was 0.98. The pain subscale showed a Cron-
bachs Alpha of 0.93 and the function subscale 0.97. Ana-
lysis of the internal consistency for the LE patients alone
showed a Crohnbach’s alpha of 0.93. The pain subscale
showed a Crohnbach’s alpha of 0.80 and the function
subscale 0.91 in the analysis of the LE patients. A factor
analysis revealed one factor (eigenvalue = 12.04) with an
explained variance of 80.3%.
Table 1 Subject characteristics and descriptive statistics of the PRTEE-D, DASH and VAS pain scores
Measure Participants test-retest reliability n = 122 (mean, SD) Participants construct validity n = 30 (mean, SD)
Age (years) 28.8 (13.5) 45.6 (8.9)
Height (cm) 175.1 (9.1) 176.1 (11.8)
Weight (kg) 73.0 (15.4) 89.9 (16.5)
Duration of symptoms (months) 6.6 (25.6) 20.0 (44.1)
Hours sports per week 3.9 (3.0) 3.2 (1.4)
PRTEE-Da 14.8 (24.1) 51.5 (18.3)
PRTEE-D pain subscorea 8.1 (12.7) 26.9 (8.6)
PRTEE-D function subscorea 6.7 (11.8) 24.6 (10.8)
DASH score 36.7 (18.9)
VAS pain score 56.8 (21.8)
% LE patients 26% 100%
aThe first PRTEE-D measurement is used to calculate the mean score. PRTEE-D = Patient Rated Tennis Elbow Evaluation-Dutch, DASH = Disabilities for the Arm,
Shoulder and Hand questionnaire, VAS = Visual Analogue Scale, LE = Lateral Epicondylalgia, SD = Standard Deviation.
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Table 2 shows the ICCs of the total score of PRTEE-D,
subscales and individual items. ICC (2,1) values showed
excellent test-retest reliability for the PRTEE-D, sub-
scales and all individual questions. ICC values (2,1) for
the LE patients alone showed also excellent test-retest
reliability for the PRTEE and subscales. Individual ques-
tions 1,2,4,8 and 9 had fair to good test-retest reliability,
the other questions had excellent test-retest reliability
for LE patients only. The Minimal Detectable Change
for the PRTEE-D was 9.1, MDC was 5.43 for the pain
subscale and 5.62 for the function subscale. Figure 1
shows the Bland and Altman plot of the PRTEE-D and
Figure 2 shows this plot for LE patients only. Absolute
agreement was not assumed for the PRTEE-D and pain
subscale. The mean difference between test and retestTable 2 Test-retest reliability (ICC, SEM and MDC) of the PRTE
Pain subscale Functio







1 .87 (.81-.91) .69 (.45-.84) .67 1.86 6
2 .96 (.94-.97) .71 (.42-.86) .57 1.59 7
3 .94 (.92-.96) .78 (.58-.89) .71 1.96 8
4 .77 (.68-.83) .59 (.30-.78) .59 1.64 9






Pain subscale .97 (.95-.98) .78 (.57-.90) 1.96 5.43 Functio
PRTEE-D
ICC = Intra Class Correlation, CI = Confidence Interval, SEM = Standard Error of Measufor the PRTEE-D total score was 0.97 with a 95% CI of
0.11-1.83; The mean difference of the pain subscale was
0.61 with a 95% CI of 0.05-1.17. The mean difference
for the PRTEE-D total score for LE patients only was
3.74 with a 95% CI of 0.49-7.00; the mean difference of
the pain subscale for LE patients only was 2.58 with a
95% CI of 0.55-4.61. Absolute agreement was assumed
for the function scale (mean difference 0.35, 95% CI
(−0.13-0.83)), this was also the case for the LE patients
only (mean difference 1.16, 95% CI −0.75-3.10).
Construct validity
Spearman’s correlation coefficients between PRTEE-D
(subscales) and VAS pain and DASH score are provided
in Table 3. The Spearman coefficients showed moderate
correlations between PRTEE-D and DASH and VASE-D, subscales and individual questions
n subscale




.92 (.88-.94) .78 (.59-.89) .59 1.64
.94 (.91-.96) .82 (.66-.91) .66 1.83
.91 (.87-.93) .73 (.50-.86) .60 1.67
.94 (.91-.96) .74 (.53-.87) .68 1.90
.94 (.92-.96) .87 (.75-.94) .47 1.29
.93 (.91-.95) .77 (.56-.89) .71 1.97
.92 (.88-.94) .82(.65-.91) .50 1.37
.95 (.93-.96) .84 (.69-.92) .54 1.49
.97 (.95-.98) .89 (.79-.88) .45 1.25
.96 (.94-.97) .88 (.76-.94) .52 1.45
n subscale .97 (.96-.98) .89 (.79-.95) 2.03 5.62
overall (total) .98 (.97-.99) .88 (.75-.94) 3.28 9.10
rement, MDC =Minimal Detectable Change.
Figure 1 Bland and Altman plot of reliability (agreement) of the PRTEE-D (2 measures).
Figure 2 Bland and Altman plot of reliability (agreement) of the PRTEE-D (2 measures) for LE patients.
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Table 3 Spearman’s correlation coefficients between PRTEE-D (subscales) and VAS pain and DASH score
Measure PRTEE-D score (p-value) PRTEE-D pain subscale (p-value) PRTEE-D function subscale (p-value)
DASH score .65 (<0.01) .45 (0.01) .67 (<0.01)
VAS pain score .68 (<0.01) .55 (<0.01) .70 (<0.01)
PRTEE-D = Patient Rated Tennis Elbow Evaluation-Dutch, DASH = Disabilities for the Arm, Shoulder and Hand questionnaire, VAS = Visual Analogue Scale.
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the DASH score and a moderate correlation with VAS
pain score. A moderate correlation was found between
function subscale and DASH score and a high correl-
ation was found between function subscale and VAS
pain score. All correlations were significant. Figure 3
shows the Bland and Altman plot of construct validity of
the PRTEE-D. The mean difference between PRTEE-D
and DASH score was 14.81 with a 95% CI of 9.04-20.57.
Absolute agreement was not assumed between PRTEE-
D and DASH score.Discussion
Since no reliable and valid Dutch questionnaire existed
to determine the severity of LE, this study aimed to
translate and cross-culturally adapt the PRTEE for
Dutch speaking LE patients. Semantic, idiomatic, experi-
ential and conceptual equivalence to the original PRTEE
questionnaire was assured by applying the guidelines for
the process of cross-cultural adaptation of self-report
measures [16].Figure 3 Bland and Altman plot of construct validity PRTEE-D.Furthermore, reliability and validity of the PRTEE-D
were determined. The total PRTEE-D score as well as
the pain and function subscales demonstrated excellent
internal consistency and test-retest reliability. All Spear-
man correlation coefficients were significant and most
coefficients showed moderate correlations. We believe
that these data showed good construct validity of the
PRTEE-D. It can be concluded that the PRTEE-D was
successfully cross-culturally adapted and is found to be a
reliable and valid instrument to measure pain and func-
tional ability in Dutch speaking patients with LE.
Cronbach’s alpha for the PRTEE-D was 0.98, this
indicates an excellent internal consistency. An alpha
coefficient > 0.9 is recommended for the use of a ques-
tionnaire in a clinical setting [24]. The value of Cron-
bach’s alpha is even slightly higher than the Cronbach’s
alpha for the Italian (0.95), English (0.94), Swedish
(0.94), Canadian-French (0.93) and Turkish (0.84) trans-
lations of the PRTEE [11-14,25]. The pain (0.93) and
function (0.97) subscales also showed excellent internal
consistencies. These Crohnbach’s alpha values are also a
little higher than the values found in other translations
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lower, but still excellent values were found (0.93 total
PRTEE-D, 0.80 pain subscale and 0.91 function
subscale).
The ICC values show excellent values for test-retest reli-
ability, ICC of the PRTEE-D was 0.98. The same is true
for the ICC value of the pain subscale (0.97) and function
subscale (0.97), all individual questions also showed excel-
lent test-retest reliability. Test-retest reliability is in ac-
cordance with ICC values of the original questionnaire;
Overend et al [8] and Newcomer et al. [9] respectively
found an ICC value of 0.89 and 0.96. This also holds for
the pain and function subscales, ICC values of 0.96 and
0.89 were found for the pain subscale in the original ques-
tionnaire and 0.92 and 0.83 for the function subscale [8,9].
PRTEE questionnaires in other languages show compar-
able results [13,15]. The ICC values for the LE patients
only, show lower correlations, but the values of the
PRTEE-D and subscales are still excellent and comparable
to previous studies. A systematic bias is assumed for the
PRTEE-D total score and pain subscale, because the 95%
CI of the difference did not contain zero. The PRTEE-D
score on the second assessment showed an almost 1 point
higher score than the first measurement, LE patients
showed a 3.7 point higher score on the second measure-
ment. This might be explained by an actual improvement
of symptoms due to for example treatments performed
during this interval. A minor improvement is consistent
with what can be expected from the literature [26]. No
constraints on treatment were imposed because of ethical
considerations. Most of the other studies which investi-
gated test-retest reliability of the PRTEE used a shorter
time interval than the one week used in this study to pre-
vent an alteration in the severity of symptoms. A one week
period was chosen in this study to prevent ‘copying’ from
a subject’s memory and no longer to prevent major
changes in symptoms [17].
VAS-pain and DASH questionnaire were chosen to
determine construct validity of the PRTEE-D by calculat-
ing Spearman’s correlations, because an instrument that
can be considered the gold standard for LE patients does
not exist. The Dutch language version of the DASH
questionnaire was found to be reliable and valid to as-
sess disability and symptoms in patients with upper limb
disorders [18] and VAS-pain provides an indication of
pain of a LE patient. Across the different adaptation
studies, several measurement tools were used to assess
validity. We believe that at least the DASH should be
used to assess construct validity, because this is probably
the best alternative for the PRTEE, being a validated
questionnaire designed to measure upper limb disabil-
ities and symptoms [19]. The DASH was used in four of
the seven PRTEE adaptation studies. Other measure-
ment tools used to assess validity were among others theRoles and Maudsley test, VAS-pain, pain free grip and
maximal grip strength. Results showed a moderate
spearman correlation (0.68) between PRTEE-D (total)
and VAS-pain scores. This is in resemblance with the
original questionnaire (0.66) [9] and the Canadian-
French PRTEE (0.77) [14]. A moderate correlation was
also found between PRTEE-D and DASH score (0.65).
This value is close to the correlation of the original
questionnaire with the DASH (0.72). Validation studies
of the PRTEE in other languages show similar correla-
tions with the DASH questionnaire as well (Turkish
0.68, Swedish 0.88) [11,13]. The correlation of the
PRTEE pain subscale with the DASH shows the lowest
correlation (0.45). The validation of the PRTEE in other
languages also found the lowest correlation between the
pain scale and the DASH, although the correlations were
slightly higher (0.50-0.78) [11-14,25]. The relatively low
correlation between the pain scale of the PRTEE-D and
DASH score is probably caused by the small number of
questions on pain in the DASH questionnaire. The other
correlations of the subscales with VAS and DASH show
moderate to high correlations comparable to the original
questionnaire and translations. A systematic bias was
found between PRTEE-D and DASH score. Patients
scored on average 14.8 points higher (more severe symp-
toms) on the PRTEE-D than on the DASH. An explan-
ation for the relatively low correlations and systematic
bias between PRTEE-D and DASH and VAS-pain score
is that DASH and VAS-pain were not specifically de-
signed for LE in contrast to the PRTEE. Excellent corre-
lations and absolute agreement were therefore not to be
expected. We can therefore state that correlations of
PRTEE-D with VAS-pain and DASH show good con-
struct validity for the PRTEE-D.
The methodology of cross-cultural adaptations of
(previous versions) of the PRTEE slightly differs. All but
one of the previous cross-cultural adaptations of the
PRTEE used the criteria proposed by Beaton et al. [16].
This comprehensive and well described way of cross-
culturally adapting questionnaires seems justified. All
the studies which investigated test-retest reliability pro-
vided ICC values and all except one provided Cron-
bach’s alpha values [15]. One of the studies investigating
the PRTEE only investigated validity [14]. To be able to
use a questionnaire in clinical practice or research, suffi-
cient reliability and validity are desirable.
A large number of participants were included in this
study to investigate test-retest reliability; however a limi-
tation of this study is that in contrast to other reliability
and validity studies of the PRTEE a high number of par-
ticipants without complaints was used. This might have
positively influenced test-retest reliability values. How-
ever, analysis of the LE patients only showed only
slightly lower values, indicating that the influence of
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The LE patients included in the study seem to be a repre-
sentative sample, because they were recruited in several
(para)medical settings. Further, as also reported in the ori-
ginal and other translated versions of the PRTEE, a num-
ber of participants indicated having trouble with some
questions because they never performed that activity with
their injured arm. The best solution for this is probably to
use the average score of the subscale for this question, like
stated in the PRTEE manual for missing questions [27].
Another option, use the maximum score, seems less suit-
able because patients are most likely able to do the activity
without unbearable pain but choose the less painful option
(using their other arm). The PRTEE-D is consistent with
other versions on this subject. This has to be taken into
account when for example considering a LE patient with
his/her non-dominant arm affected. Another limitation is
that no constraints were imposed on treatments between
the first and second measurement, this is however not
possible due to ethical considerations. This study did not
study the responsiveness of the PRTEE-D, further re-
search still needs to address the responsiveness of this
questionnaire.
Conclusion
While Lateral Epicondylalgia is a common injury, to our
knowledge no reliable and valid Dutch outcome measure
specific to LE existed so far. This study showed that the
PRTEE-D is successfully cross-culturally adapted and is
a reliable and valid tool to measure severity of LE. It can
be used as an assessment and evaluation tool, for ex-
ample to monitor or determine the effects of a treat-
ment. With the Dutch PRTEE Dutch speaking clinicians
as well as researchers are now provided with a reliable,
valid and easy-to-use instrument. Moreover, it is now
possible to compare Dutch results from research on LE
to international data [16].
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